US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

1  2  3  4    6    8  9  10  
Modified Starch Products Derivatives & Markets – A Strategic Review March 2015
3/1/2015 | published by: S.K. Patil and Associates
... report has new chapters on Future Wet Mill Capacity and New Starch Capacity Perspective (chapter VII) and a brand new addition (chapter IX) Waxy Starch Characteristics and Perspective. There is also information on the modified ...  |  read more...
USD 3,900
Gene Therapy Market, 2015 - 2025
2/25/2015 | published by: Roots Analysis
... or delete the genes causing a particular disease is known as gene therapy. Although gene therapy has not contributed significantly to the global pharmaceutical market yet, it is anticipated to grow at a fast pace ...  |  read more...
USD 2,199
Biomarker Deals and Alliances of 2014
3/1/2015 | published by: Current Partnering
... during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
Antibody Deals and Alliances of 2014
3/1/2015 | published by: Current Partnering
... during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
Clinical Stage Deals and Alliances of 2014
3/1/2015 | published by: Current Partnering
... healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Acorda Therapeutics, Inc. (ACOR) - Financial and Strategic SWOT Analysis Review
3/3/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
AnGes MG, Inc. (4563) - Financial and Strategic SWOT Analysis Review
3/3/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Discovery Stage Deals and Alliances of 2014
3/1/2015 | published by: Current Partnering
... healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Public Health Deals and Alliances of 2014
3/1/2015 | published by: Current Partnering
... healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Hospital Care Deals and Alliances of 2014
3/1/2015 | published by: Current Partnering
... healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Regulatory Trends in the US Pharma/Biotech Industry
2/26/2015 | published by: Frost & Sullivan
... industry, with the highest number of NMEs approved in the last decade. In terms of highest number of filings, regulatory submissions were at their peak in 2014, tied with 2011 and 2012. The number of ...  |  read more...
USD 1,500
Global Predictive Breast Cancer Gene Testing Industry 2015 Market Research Report
3/10/2015 | published by: 9Dimen Research
... main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Predictive Breast Cancer Gene Testing basics: definitions, classifications, applications and industry chain overview; ...  |  read more...
USD 2,850
Global Biochip Industry 2015 Market Research Report
1/30/2015 | published by: 9Dimen Research
... the main countries (United States, Germany, Japan and China). The report firstly introduced the Biochip basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so ...  |  read more...
USD 2,850
Panacea Biotec Limited (PANACEABIO) - Financial and Strategic SWOT Analysis Review
3/10/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Thrombus Partnering 2010-2015
3/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Thrombus Partnering 2010-2015 provides understanding and access to the thrombus partnering deals and agreements entered into by the worlds ...  |  read more...
USD 795
Northwest Biotherapeutics, Inc. (NWBO) - Financial and Strategic SWOT Analysis Review
2/17/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Oxford Nanopore Technologies Ltd. - Strategic SWOT Analysis Review
2/23/2015 | published by: GlobalData
... company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. ...  |  read more...
USD 125
Therametrics holding AG (TMX) - Financial and Strategic SWOT Analysis Review
2/23/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Analysis of Agenus Inc
3/1/2015 | published by: Aruvian's R'search
... of various cancers and infectious diseases. The company has in place a strong research and development team along with a strong portfolio of intellectual properties. Aruvian’s R’search presents Analysis of Agenus Inc. A complete and ...  |  read more...
USD 300
Analysis of Genentech, Inc.
3/1/2015 | published by: Aruvian's R'search
... as cancer, angiogenic disorders, immunological diseases and others. Rituxan, Herceptin, Xolair, Activase, etc., are some of the company's major products that are well known around the world. Aruvian’s R’search presents Analysis of Genentech Inc. A ...  |  read more...
USD 300
Metagenics, Inc. - Strategic SWOT Analysis Review
2/9/2015 | published by: GlobalData
... key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business description ...  |  read more...
USD 125
Water Analysis Instrumentation (Laboratory-based and Online)
2/1/2015 | published by: Global Industry Analysts
... analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these ...  |  read more...
USD 4,950
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015
3/1/2015 | published by: DelveInsight
... provides the marketed and pipeline scenario of the ADCs. The Report has covered the 264 Antibody-drug conjugates profile which gives core information of the targets, mechanism of action, development partner, Technology partner, monoclonal antibody used, ...  |  read more...
USD 3,500
Celgene Corporation (CELG) - Financial and Strategic SWOT Analysis Review
3/10/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Global Polypeptide Drug Industry
3/1/2015 | published by: QYResearch Group
... chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analysis, the report analyzes Polypeptide Drug markets in China and other countries or regions (such as US, Europe, Japan, etc) ...  |  read more...
USD 2,600
1  2  3  4    6    8  9  10